A | (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 
。
B | 1月10日消息根据“小米赛车”微信公开消息，“小米赛车”全频道预订开通，1月15日正式公开测试。官员们说，他们还将为100辆米粉赛车打气。
C | 官员们说，在即将发布的“小米赛车”游戏中，这辆珍贵的AE86赛车沉重的建造，给了米粉。
D | AE86是“小米赛车”游戏中非常罕见的一款汽车。
E | 作为比赛中特殊杯赛的“票”，它不仅可以在比赛中交换先进的道具，还可以在后期以物质奖励的形式参加特殊赛事。官员们说，“小米赛跑”试图恢复真正的赛车体验。这款游戏包含了赛车的不同风格和特点，包括大黄蜂、有趣的夜总会时髦男人、英俊酷的勒芒之王、寡妇制造商等。无论你喜欢什么款式，你都可以在“小米赛跑”中找到你最喜欢的车。小米赛车官方网站预订地址：点击此处访问。
Current article:http://www.chenzhuaigecoupuhongyuntuizei.sbs/93x/20260826/3894.html
Published on:03:42:10
